That's completely false, of course. If they were seeing excellent results the trial would either be stopped and put on an accelerated path for commercialization or opened up for additional patients. Both would require an immediate press release. Neither one happened.
The company needs cash badly. We have issues with Nasdaq which need fixing We have total silence over P3 including a screening of new patients. We have silence over the investigation, German Insurance and UK fast track We have silence on Direct We have no updates on Manufacturing capabilities in Sawston We have all witnessed a 90% drop in the stock Good news is greeted with stock pressure We have weak board governance We don't even have a date for the AGM on the website for investors to challenge management. We are witnessing widespread lack of institutional investor confidence or interest based on all of the above
And you think your best interests are served by no news on a continued basis = Better news to come.
Market Data 
Markets 
AI
